Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Black Diamond Therapeutics (BDTX) Shares Issued (2020 - 2025)

Black Diamond Therapeutics' Shares Issued history spans 4 years, with the latest figure at -$32000.0 for Q2 2025.

  • For Q2 2025, Shares Issued fell 100.15% year-over-year to -$32000.0; the TTM value through Jun 2025 reached -$500000.0, down 101.9%, while the annual FY2024 figure was $24.5 million, 29770.73% up from the prior year.
  • Shares Issued reached -$32000.0 in Q2 2025 per BDTX's latest filing, down from $32000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $21.0 million in Q2 2024 to a low of -$500000.0 in Q3 2024.
  • Average Shares Issued over 3 years is $4.2 million, with a median of $256500.0 recorded in 2021.
  • The largest YoY upside for Shares Issued was 99.2% in 2025 against a maximum downside of 100.15% in 2025.
  • A 3-year view of Shares Issued shows it stood at $481000.0 in 2021, then crashed by 203.95% to -$500000.0 in 2024, then surged by 93.6% to -$32000.0 in 2025.
  • Per Business Quant, the three most recent readings for BDTX's Shares Issued are -$32000.0 (Q2 2025), $32000.0 (Q1 2025), and -$500000.0 (Q3 2024).